Lv11
10 积分 2026-04-26 加入
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
6小时前
待确认
Juyuanjian attenuates sarcopenia through dual regulation of the Akt/FoxO1 and SIRT1/PGC-1α pathways
3天前
已完结
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)
25天前
已完结
皖公网安备34019202002308
